NA Semax Amidate Research: Stabilised ACTH(4-10) Analogue

NA Semax Amidate (N-Acetyl Semax Amidate) is the most metabolically stable form of the Semax heptapeptide research tool. It incorporates two terminal modifications — N-terminal acetylation and C-terminal amidation — that together protect against both aminopeptidase (N-terminal) and carboxypeptidase (C-terminal) enzymatic degradation, extending biological stability without altering the central pharmacophore.

The Semax Family: Three Stability Levels

Each modification addresses a specific enzymatic vulnerability. Standard Semax has the Pro-Gly-Pro C-terminal extension that already provides some carboxypeptidase resistance (proline is a poor carboxypeptidase substrate), but free aminopeptidase attack at the N-terminal Met remains. N-acetylation blocks this, while C-terminal amidation replaces the free carboxylic acid that could still be processed by some carboxypeptidases.

Pharmacophore Preservation

The central receptor-interacting region of Semax — the ACTH(4-10)-derived core Met-Glu-His-Phe-Pro-Gly-Pro — is completely preserved in NA Semax Amidate. Neither N-terminal acetylation nor C-terminal amidation alters the mid-sequence pharmacophore responsible for biological activity in BDNF, dopaminergic, and serotonergic research models.

This preservation of the central pharmacophore with modified termini is the fundamental principle of terminus-protected neuropeptide design — frequently used in medicinal chemistry to create stable research tools from naturally occurring peptide sequences.

Research Applications

NA Semax Amidate is used in the same experimental contexts as standard Semax but provides important advantages in:

Extended incubation studies. For cell culture experiments lasting more than a few hours, standard Semax may be degraded to sub-active concentrations before the endpoint. NA Semax Amidate maintains higher effective concentrations over extended incubation periods.

In vivo pharmacokinetics. When characterising systemic distribution and tissue penetration, NA Semax Amidate's extended half-life enables detection at later time points and provides more reliable plasma concentration-time profiles.

Stability-activity relationship research. Systematic comparison of standard Semax versus NA Semax Amidate in the same assay system allows researchers to quantify the contribution of degradation to apparent concentration-response relationships.

Published Research References

Detailed Modification Effects on Stability

N-terminal acetylation mechanism. The Met1 residue in standard Semax has a free alpha-amino group that is susceptible to aminopeptidase attack. The acetyl group (CH3CO-) added to this amine in NA Semax Amidate neutralises its nucleophilicity, preventing the hydrogen bonding interactions with aminopeptidase active sites required for catalysis. N-acetylated peptides are not substrates for the vast majority of aminopeptidases — a single acetyl group provides comprehensive N-terminal protection across multiple aminopeptidase enzymes.

C-terminal amidation mechanism. The Pro7 C-terminus of standard Semax has a free carboxylic acid. While Pro is already a poor carboxypeptidase A substrate (the active site cannot accommodate Pro's cyclic side chain), amidation (-CONH2 instead of -COOH) provides additional protection by eliminating the carboxylate anion required for zinc coordination in carboxypeptidase active sites.

Research Design: Three-Way Stability Comparison

The most informative research design using the Semax family employs three parallel groups:

1. Standard Semax (Met-Glu-His-Phe-Pro-Gly-Pro)
2. NA Semax Amidate (Ac-Met-Glu-His-Phe-Pro-Gly-Pro-NH2)
3. BDNF positive control or vehicle

Comparing dose-response curves between groups 1 and 2 at the same nominal concentration allows quantification of the stability contribution. If NA Semax Amidate produces a left-shifted dose-response curve (lower EC50) or a higher Emax at the same nominal concentration, this indicates that degradation of standard Semax was limiting its effective concentration — a finding that directly informs the choice of compound for any given assay timecourse.

Research Connections

NA Semax Amidate research complements the broader neuropeptide stability research toolkit. Comparing it with NA Selank Amidate (same terminal modifications, different central pharmacophore) allows systematic investigation of how terminus protection affects pharmacodynamic parameters across different neuropeptide systems targeting distinct neurochemical pathways.

For laboratory and analytical research purposes only. Not for human or veterinary use.

Related: Standard Semax | Selank | NA Selank Amidate
View NA Semax Amidate product and buy →

The Semax Peptide Family: A Research Toolkit

Signal Labs supplies multiple members of the Semax peptide family as research tools, each providing different pharmacokinetic properties with the same central pharmacophore:

Standard Semax (Met-Glu-His-Phe-Pro-Gly-Pro): The reference compound with unmodified termini. Most data from published Russian research used this form. Moderate stability in biological media (Pro-Gly-Pro C-terminal provides some carboxypeptidase resistance, but Met1 is aminopeptidase-vulnerable).

NA Semax Amidate (Ac-Met-Glu-His-Phe-Pro-Gly-Pro-NH2): Maximum terminus stability. Both termini protected against exopeptidase attack. Extended half-life in plasma and cell culture media. Preferred for long-duration experiments. Same central pharmacophore as standard Semax.

Semax+Selank Blend: Combines standard Semax with standard Selank for dual-system neurochemical research covering ACTH/BDNF/dopaminergic (Semax) and GABAergic/opioidergic (Selank) pathways simultaneously.

For researchers choosing between standard Semax and NA Semax Amidate, the decision should be based on: (1) assay duration — short assays (less than 4 hours) show minimal stability difference; long assays (greater than 12 hours) benefit substantially from NA Semax Amidate's stability advantage; (2) mechanistic attribution intent — if the research aims to reproduce published Russian data using standard Semax, use standard Semax; if the research aims for maximum pharmacological control, use NA Semax Amidate.

ACTH(4-10) Pharmacology: Parent Sequence Biology

Understanding ACTH(4-10) (Met-Glu-His-Phe-Arg-Trp-Gly) provides essential context for NA Semax Amidate research. ACTH(4-10) is the core behavioural pharmacophore of ACTH — the seven amino acid sequence that retains the cognitive and neuroprotective effects of the 39 amino acid ACTH peptide without adrenocortical stimulation (which requires residues beyond position 10).

Published research from the 1970s-80s by de Wied and colleagues established ACTH(4-10) as a neuropeptide with effects on learning, memory, and stress resilience in rodent models. The subsequent development of Semax — adding Pro-Gly-Pro to improve stability — extends this ACTH(4-10) research programme with a more practical research tool. NA Semax Amidate further extends stability while preserving the complete ACTH(4-10) pharmacophore.

Frequently Asked Questions

What is the evidence that the Pro-Gly-Pro extension has biological activity independent of Semax?
Pro-Gly-Pro (glycine-proline-hydroxyproline-related tripeptide) is an established bioactive compound in its own right — a product of collagen degradation that serves as a chemoattractant for leukocytes and has been studied in the context of tissue remodelling and ECM biology. Stavchansky et al. (Journal of Peptide Science, 2015) examined Pro-Gly-Pro alongside Semax in rat ischaemia models and reported that Pro-Gly-Pro itself showed some neuroprotective activity, though less than the full Semax sequence. This suggests that some of Semax's effects may be partially attributable to the Pro-Gly-Pro moiety rather than entirely to the ACTH(4-10) core, which complicates mechanistic interpretation of Semax research.

How does the Met1 residue in Semax affect research compared to the analogues without it?
Met1 in Semax and NA Semax Amidate is susceptible to oxidation — methionine sulphoxide (Met[O]) formation can occur during storage or during cell culture incubation under oxidative conditions. Met oxidation can reduce biological activity by altering the peptide's N-terminal geometry and its interaction with target receptors or enzymes. For research in oxidative stress models or in cell culture conditions with elevated ROS, researchers should be aware that Met oxidation may progressively reduce effective Semax/NA Semax Amidate concentration during extended experiments. Fresh preparation and including antioxidants (vitamin C, N-acetylcysteine) in buffers can reduce Met oxidation during experiments.

Browse all Signal Labs research peptides | Peptide storage guide | Reconstitution guide